Suchergebnisse - "Mouraud, Séverine"

PubPharm (17)

1

Correction : Metabolomic analyses of COVID-19 patients unravel stage-dependent and prognostic biomarkers

enthalten in: Cell death & disease | 2024

von Danlos, F. | Grajeda-Iglesias, C. | Durand, S. | +37

ErratumFor: Cell Death Dis. 2021 Mar 11;12(3):258. - PMID 33707411

2

Immune Checkpoints are Predominantly Co-Expressed by Clonally Expanded CD4+FoxP3+ Intratumoral T-cells in Primary Human Cancers

enthalten in: ResearchSquare.com | 2023

von Bredel, D. | Tihic, E. | Mouraud, S. | +32

3

Immune checkpoints are predominantly co-expressed by clonally expanded CD4+FoxP3+ intratumoral T-cells in primary human cancers

enthalten in: Journal of experimental & clinical cancer research : CR | 2023

von Bredel, D. | Tihic, E. | Mouraud, S. | +33

4

Immune checkpoints are predominantly co-expressed by clonally expanded $ CD4^{+} %$ FoxP3^{+} $ intratumoral T-cells in primary human cancers

enthalten in: Journal of experimental & clinical cancer research | 2023

von Bredel, D. | Tihic, E. | Mouraud, S. | +33

5

Genomic Instability and Protumoral Inflammation Are Associated with Primary Resistance to Anti-PD-1 + Antiangiogenesis in Malignant Pleural Mesothelioma

enthalten in: Cancer discovery | 2023

von Danlos, F. | Texier, M. | Job, B. | +40

6

Feasibility, safety and efficacy of human intra-tumoral immuno-therapy. Gustave Roussy's initial experience with its first 100 patients

enthalten in: European journal of cancer (Oxford, England : 1990) | 2022

von Tselikas, L. | Dardenne, A. | de Baere, T. | +20

7

Safety, recommended dose, efficacy and immune correlates for nintedanib in combination with pembrolizumab in patients with advanced cancers

enthalten in: Journal of experimental & clinical cancer research : CR | 2022

von Baldini, C. | Danlos, F. | Varga, A. | +34

8

Safety, recommended dose, efficacy and immune correlates for nintedanib in combination with pembrolizumab in patients with advanced cancers

enthalten in: Journal of experimental & clinical cancer research | 2022

von Baldini, C. | Danlos, F. | Varga, A. | +34

9

Safety, recommended dose, efficacy and immune correlates for nintedanib in combination with pembrolizumab in patients with advanced cancers

enthalten in: Journal of experimental & clinical cancer research | 2022

von Baldini, C. | Danlos, F. | Varga, A. | +34

10

Neuropilin-1 cooperates with PD-1 in CD8+ T cells predicting outcomes in melanoma patients treated with anti-PD1

enthalten in: iScience | 2022

von Rossignol, J. | Belaid, Z. | Fouquet, G. | +35